ALTERYX INC [AYX], ALIBABA GROUP [BABA], BAIDU INC [BIDU], CATERPILLAR INC [CAT], CELLULAR BIOMEDICINE GROUP [CBMG], CAREDX INC [CDNA], CODEXIS INC [CDXS] Price Technical Analysis Elliott Wave and Trading Levels  - tradinglounge

ALTERYX INC [AYX] (NYSE)
Alteryx is an American computer software company based in Irvine, California, with a development center in Broomfield, Colorado. The company's products are used for data science and analytics. The software is designed to make advanced analytics accessible to any data worker.

ALIBABA GROUP [BABA] (NYSE - ADR)
Alibaba Group Holding Limited, also known as Alibaba Group and as Alibaba.com, is a Chinese multinational technology company specializing in e-commerce, retail, Internet, and technology

BAIDU INC [BIDU] (NASDAQ - ADR)
Baidu, Inc. is a Chinese multinational technology company specializing in Internet-related services and products and artificial intelligence, headquartered in Beijing's Haidian District. It is one of the largest AI and internet companies in the world.

CATERPILLAR INC [CAT] (NYSE)
Caterpillar Inc. is an American Fortune 100 corporation which designs, develops, engineers, manufactures, markets, and sells machinery, engines, financial products, and insurance to customers via a worldwide dealer network. It is the world's largest construction equipment manufacturer.

CELLULAR BIOMEDICINE [CBMG] (NASDAQ)
Cellular Biomedicine Group, Inc. operates as a biopharmaceutical company. The Company develops cell therapies for the treatment of cancer and degenerative diseases. Cellular Biomedicine Group serves patients in China and the United States

CAREDX INC [CDNA] (NASDAQ)
CareDx CareDx, Inc. is a leading precision medicine solutions company focused on the discovery, development and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers.

CODEXIS [CDXS] (NASDAQ)
Codexis, Inc. is a leading protein engineering company that applies its CodeEvolver platform technology to create high-performing enzymes for improving the cost and quality of pharmaceuticals and food

Risk Disclaimer

As with any day trading or investing opportunity there is a risk of losing part or all of your capital that Trading Lounge expresses opinions on.

Note: Historical trading results are no guarantee of future returns.

Some investments are inherently more risky than others.  At worst, you could lose your entire investment and more, so seek financial advice from your financial adviser.

TradingLounge™ uses a range of technical analysis tools, such as Elliott Wave, software and basic fundamental analysis as well as economic forecasts aimed at minimising the potential for loss.  

The advice we provide through our TradingLounge™ websites and our TradingLounge™ Membership and social media platforms has been prepared without taking into account your particular objectives, financial situation or needs. Reliance on such advice, information or data is at your own risk.

The decision to trade and the method of trading is for you alone to decide, tradinglounge takes no responsibility whatsoever for your trading profits or losses.

This information is of a general nature only, so you should, before acting upon any of the information or advice provided by us, 
consider the appropriateness of the advice in light of your own objectives, financial situation or needs. 
Therefore, you should consult your financial advisor or accountant to determine whether trading in Indices ETFs Stocks shares Forex  CFDs Options Spread Betting
derivatives of any kind / products are appropriate for you in light of your financial trading circumstances.

As with any investment opportunity there is a risk of making losses on investments that Trading Lounge expresses opinions on.

Historical results are no guarantee of future returns. Some investments are inherently riskier than others. At worst, you could lose your entire investment. TradingLounge™ uses a range of technical analysis tools, software and basic fundamental analysis as well as economic forecasts aimed at minimizing the potential for loss.

The advice we provide through our TradingLounge™ websites and our TradingLounge™ Membership has been prepared without considering your objectives, financial situation or needs. Reliance on such advice, information or data is at your own risk. The decision to trade and the method of trading is for you alone to decide. This information is of a general nature only, so you should, before acting upon any of the information or advice provided by us, consider the appropriateness of the advice considering your own objectives, financial situation or needs. Therefore, you should consult your financial advisor or accountant to determine whether trading in securities and derivatives products is appropriate for you considering your financial circumstances.

Recommended Content


Recommended Content

Editors’ Picks

AUD/USD rises to two-day high ahead of Aussie CPI

AUD/USD rises to two-day high ahead of Aussie CPI

The Aussie Dollar recorded back-to-back positive days against the US Dollar and climbed more than 0.59% on Tuesday, as the US April S&P PMIs were weaker than expected. That spurred speculations that the Federal Reserve could put rate cuts back on the table. The AUD/USD trades at 0.6488 as Wednesday’s Asian session begins.

AUD/USD News

EUR/USD holds above 1.0700 on weaker US Dollar, upbeat Eurozone PMI

EUR/USD holds above 1.0700 on weaker US Dollar, upbeat Eurozone PMI

EUR/USD holds above the 1.0700 psychological barrier during the early Asian session on Wednesday. The weaker-than-expected US PMI data for April drags the Greenback lower and creates a tailwind for the pair. 

EUR/USD News

Gold price cautious despite weaker US Dollar and falling US yields

Gold price cautious despite weaker US Dollar and falling US yields

Gold retreats modestly after failing to sustain gains despite fall in US Treasury yields, weaker US Dollar. XAU/USD struggles to capitalize following release of weaker-than-expected S&P Global PMIs, fueling speculation about potential Fed rate cuts.

Gold News

Ethereum ETF issuers not giving up fight, expert says as Grayscale files S3 prospectus

Ethereum ETF issuers not giving up fight, expert says as Grayscale files S3 prospectus

Ethereum exchange-traded funds theme gained steam after the landmark approval of multiple BTC ETFs in January. However, the campaign for approval of this investment alternative continues, with evidence of ongoing back and forth between prospective issuers and the US SEC.

Read more

Australia CPI Preview: Inflation set to remain above target as hopes of early interest-rate cuts fade

Australia CPI Preview: Inflation set to remain above target as hopes of early interest-rate cuts fade

An Australian inflation update takes the spotlight this week ahead of critical United States macroeconomic data. The Australian Bureau of Statistics will release two different inflation gauges on Wednesday.

Read more

Majors

Cryptocurrencies

Signatures